Arizona State Retirement System increased its holdings in shares of Tilray Inc (NASDAQ:TLRY – Free Report) by 8.2% during the 4th quarter, HoldingsChannel reports. The firm owned 204,148 shares of the company’s stock after purchasing an additional 15,449 shares during the period. Arizona State Retirement System’s holdings in Tilray were worth $470,000 as of its most recent SEC filing.
Several other institutional investors have also modified their holdings of TLRY. Mercer Global Advisors Inc. ADV lifted its stake in Tilray by 10.0% in the 3rd quarter. Mercer Global Advisors Inc. ADV now owns 28,072 shares of the company’s stock valued at $77,000 after acquiring an additional 2,550 shares in the last quarter. Rhumbline Advisers lifted its stake in Tilray by 20.4% in the 2nd quarter. Rhumbline Advisers now owns 15,464 shares of the company’s stock valued at $48,000 after acquiring an additional 2,623 shares in the last quarter. CreativeOne Wealth LLC lifted its stake in Tilray by 8.0% in the 3rd quarter. CreativeOne Wealth LLC now owns 40,591 shares of the company’s stock valued at $112,000 after acquiring an additional 2,994 shares in the last quarter. State of Wyoming raised its stake in shares of Tilray by 17.0% during the 4th quarter. State of Wyoming now owns 24,561 shares of the company’s stock worth $66,000 after purchasing an additional 3,564 shares in the last quarter. Finally, Mariner LLC raised its stake in shares of Tilray by 11.1% during the 4th quarter. Mariner LLC now owns 49,469 shares of the company’s stock worth $133,000 after purchasing an additional 4,945 shares in the last quarter. Institutional investors own 9.35% of the company’s stock.
Analyst Upgrades and Downgrades
A number of brokerages have recently issued reports on TLRY. Alliance Global Partners upped their price objective on Tilray from $2.25 to $2.75 and gave the stock a “neutral” rating in a research note on Friday, April 5th. CIBC dropped their price target on Tilray from $2.25 to $2.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 10th. Finally, Canaccord Genuity Group dropped their price target on Tilray from $4.25 to $4.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th.
Tilray Stock Performance
Shares of TLRY stock opened at $1.73 on Friday. The business’s 50-day moving average price is $1.96 and its 200-day moving average price is $1.95. Tilray Inc has a 12 month low of $1.50 and a 12 month high of $3.40. The firm has a market capitalization of $1.28 billion, a price-to-earnings ratio of -3.93 and a beta of 2.36. The company has a current ratio of 1.92, a quick ratio of 1.18 and a debt-to-equity ratio of 0.11.
About Tilray
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Further Reading
- Five stocks we like better than Tilray
- P/E Ratio Calculation: How to Assess Stocks
- MarketBeat Week in Review – 4/15 – 4/19
- What Are Dividends? Buy the Best Dividend Stocks
- Comprehensive Analysis of PayPal Stock
- Options Trading – Understanding Strike Price
- Intuitive Surgical Stock Can Trend Much Higher This Year
Want to see what other hedge funds are holding TLRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tilray Inc (NASDAQ:TLRY – Free Report).
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.